Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A double-blind, placebo-controlled, randomised, parallel-group, phase-II, multi-centre study to assess the efficacy, safety and tolerability of 4 twice daily doses and 2 once daily doses of AZD1981 given as tablets during 12 weeks in asthmatic patients treated with inhaled corticosteroids and long-acting-β2-agonists https://kusajili.com:443/Trial/MK7rW9BfOkuMhu9zjhqvCg%24a-double-blind-placebo-controlled-randomised-parallel-group-phase-ii-multi-centre-study-to-assess-the-efficacy-safety-and-toler
I have read and accept the terms of use of the site and the Privacy Policy
Send your message